跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
首页
药物
mRNA-DC-CTL
mRNA-DC-CTL
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MRNA-DC (Dendritic Cell) lung cancer therapeutic vaccine, preparation method thereof and CTL cell
申请人: ISTEM REGENERATIVE MEDICINE SCI TECH CO LTD
优先权: 2015
CN
Vaccine for treating mRNA-DC lung cancer, enhanced preparation method of vaccine and CTL cell
申请人: ISTEM REGENERATIVE MEDICINE SCI TECH CO LTD
优先权: 2015
CN
DC cell based on HBV1 antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
DC cell based on HBV2 antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
DC cell based on HPVE6 antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
DC cell based on AFP antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
DC cell based on HCV1 antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
DC cell based on HM1.24 antigen, targeting immune cell population, preparation method and applications thereof
申请人: YANG GUANGHUA
优先权: 2015
CN
药物
反馈